COMMUNIQUÉS West-GlobeNewswire

CLS Signs Agreement with Image Guided Therapy to Develop and Commercialize Product for MR-Generated Temperature Monitoring
17/10/2018
FRAMINGHAM, Mass., Oct. 17, 2018 (GLOBE NEWSWIRE) -- CLS AB in Lund, Sweden, with the subsidiary Clinical Laserthermia Systems Americas, Inc . (CLS Americas), today announced it has signed an agreement with Image Guided [...]
NeuroMetrix Reports Q3 2018 Financial Results
17/10/2018
$3.8M GSK Milestone; Improved Operating Performance WALTHAM, Mass., Oct. 17, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO), today reported financial and business highlights for the quarter ended September 30 [...]
Iovance Biotherapeutics, Inc. Announces Closing of $252 Million Common Stock Public Offering
17/10/2018
Offering Includes Exercise in Full of the Underwriter’s Option to Purchase an Additional 3.3 Million Shares of Common Stock SAN CARLOS, Calif., Oct. 17, 2018 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (Nasdaq: [...]
Aleafia Launches Three New Clinics, Telemedicine Treatment in Significant Expansion
17/10/2018
Six Physicians, Nurse Practitioners Also Joining Canabo Medical Clinics TORONTO, Oct. 17, 2018 (GLOBE NEWSWIRE) -- Aleafia Health Inc. ( TSXV: ALEF; OTCQX: ALEAF, FRA: ARAH ) (“ Aleafia “) or (the “Company“), one of [...]
Axsome Therapeutics Receives FDA Orphan Drug Designation for AXS-12 for the Treatment of Narcolepsy
17/10/2018
NEW YORK, Oct. 17, 2018 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, [...]
Auris Medical Announces Positive Results From Second Phase 1 Clinical Trial With Intranasal Betahistine
17/10/2018
Bioavailability significantly higher than with oral administration Treatment safe and multiple dosing well tolerated Company to move forward with planned proof-of-concept studies in acute vertigo and olanzapine-induced [...]
LHC Group Announces Third Quarter 2018 Earnings Release and Conference Call Dates
17/10/2018
LAFAYETTE, La., Oct. 17, 2018 (GLOBE NEWSWIRE) -- LHC Group, Inc . (NASDAQ: LHCG) today announced details for the release of its results for the third quarter and nine months ended September 30, 2018. LHC Group plans to [...]
Le 17 octobre : un jour comme les autres chez HEXO
17/10/2018
GATINEAU, Québec, 17 oct. 2018 (GLOBE NEWSWIRE) -- Demain, le 17 octobre 2018, sera le jour où le Canada marquera un tournant dans l’histoire de la légalisation du cannabis à usage adulte. Des célébrations sont prévues [...]
October 17: Business as usual at HEXO
17/10/2018
GATINEAU, Quebec, Oct. 17, 2018 (GLOBE NEWSWIRE) -- Today, October 17, 2018, is destined to become the day Canada made history for legalizing adult-use cannabis. Celebrations are planned across the country as all [...]
UK authority extends use of specific batches of Jext® as adrenaline pen shortage continues
17/10/2018
A shortage of adrenaline auto-injector pens continues to affect allergy sufferers worldwide Additional data from ALK allows UK authority to extend use of specific batches of Jext ® already in circulation Patients can [...]
FIT Biotech Oy: FIT Biotech's cancer patent application published
17/10/2018
FIT Biotech Oy Press release 17.10.2018 at 9.45 EET FIT Biotech's cancer patent application published FIT Biotech Oy ("Company", FITBIO: FN Finland) international patent application WO 2018/185110 has now been made [...]
Patent granted in the US
17/10/2018
AroCell announced today that the U.S. Patent and Trademark Office has granted AroCell´s patent US 10,100,128 titled ”Monoclonal Anti-TK1 Antibodies”. The patent refers to AroCell’s proprietary monoclonal antibodies that [...]
IMRALDI™, Biogen’s Adalimumab Biosimilar Referencing Humira®, Is Launched in the European Union
17/10/2018
IMRALDI TM is approved in the European Union for the same 14 complex autoimmune conditions as its reference product In 2017 Biogen became the first company in Europe with approved biosimilars referencing the three most [...]
MDxHealth Shareholder Transparency Declaration MDxHealth (R):
17/10/2018
Press release Regulated information 16 October 2018, 7.00 p.m. CET HERSTAL, BELGIUM and IRVINE, CA - October 16, 2018 - MDxHealth SA (Euronext Brussels: MDXH) ("MDxHealth" or the "Company"), announced that it received [...]
MDxHealth (R) : MDxHealth: Déclaration de Transparence d'un Actionnaire
17/10/2018
C ommuniqué de presse Information réglementée 17 octobre 2018, 07h00 HEC IRVINE, CA, et HERSTAL (BELGIQUE) - le 17 octobre 2018 - MDxHealth SA (Euronext Brussels: MDXH) ("MDxHealth" ou la "Société"), a annoncé avoir [...]
Nicox : Point d'activité et résumé financier du troisième trimestre 2018
17/10/2018
Communiqué de presse Nicox : Point d'activité et résumé financier du troisième trimestre 2018 Initiation d'une étude clinique de phase 2 pour NCX 470 au troisième trimestre 2018 pour la réduction de la pression [...]
Nicox Third Quarter 2018 Business Update and Financial Highlights
17/10/2018
Press Release Nicox Third Quarter 2018 Business Update and Financial Highlights NCX 470 Phase 2 clinical study initiated in Q3 2018 for the lowering of intraocular pressure (IOP) in patients with open-angle glaucoma or [...]
Axiom Real-Time Metrics Exhibiting at OCT Pacific Northwest in Vancouver
17/10/2018
TORONTO, Oct. 16, 2018 (GLOBE NEWSWIRE) -- Axiom Real-Time Metrics, premier provider of unified eClinical solutions and services, is exhibiting at the Outsourcing in Clinical Trials event in Vancouver, Canada October 16 [...]
Eloxx Pharmaceuticals To Report Third Quarter 2018 Financial Results and Provide Business Update On November 8, 2018
17/10/2018
Company management to host a webcast and conference call to provide a business update and review the financial results at 8:30 a.m. ET WALTHAM, Mass., Oct. 16, 2018 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc. ( [...]

Pages